Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina

被引:25
作者
Afzal-Shah, M
Villar, HE
Livermore, DM
机构
[1] Cent Publ Hlth Lab, Antibiot Reference Unit, London NW9 5HT, England
[2] Univ Catolica Argentina, Fac Post Grado Ciencias Salud, Catedra Infectol & Microbiol, RA-1107 Buenos Aires, DF, Argentina
关键词
D O I
10.1093/jac/43.1.127
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Three carbapenem-resistant Acinetobacter baumannii isolates were collected at a hospital in Buenos Aires, Argentina. Isoelectric focusing revealed multiple beta-lactamases, with two of the isolates showing identical profiles. A pl 6.9 carbapenemase with a molecular weight of 30 kDa was purified from one of these two isolates. The enzyme was predominantly a penicillinase, with its highest V-max for oxacillin but highest V-max/K-m for benzylpenicillin. First-generation cephalosporins and imipenem were weaker substrates than penicillins, and oxyimino-aminothiazolyl cephalosporins were essentially stable. Meropenem-hydrolysing activity was not detected, despite resistance. The carbapenemase was inhibited by clavulanic acid and tazobactam, but not by EDTA. These kinetics place the enzyme into functional group 2; as an oxacillinase it could be placed in sub-group 2d or, as a zinc-independent carbapenemase, in sub-group 2f.
引用
收藏
页码:127 / 131
页数:5
相关论文
共 19 条
[1]   Worldwide emergence of carbapenem-resistant Acinetobacter spp. [J].
Afzal-Shah, M ;
Livermore, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (05) :576-577
[2]   Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].
BergogneBerezin, E ;
Towner, KJ .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+
[3]   Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2 [J].
Brown, S ;
Bantar, C ;
Young, HK ;
Amyes, SGB .
LANCET, 1998, 351 (9097) :186-187
[4]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[5]  
COSTA SF, 1996, 36 INT C ANT AG CHEM, P56
[6]   Oxacillin-hydrolyzing beta-lactamase involved in resistance to imipenem in Acinetobacter baumannii [J].
Hornstein, M ;
SautjeauRostoker, C ;
Peduzzi, J ;
Vessieres, A ;
Hong, LTH ;
Barthelemy, M ;
Scavizzi, M ;
Labia, R .
FEMS MICROBIOLOGY LETTERS, 1997, 153 (02) :333-339
[7]   DISTRIBUTION OF BETA-LACTAMASES AND PHENOTYPE ANALYSIS IN CLINICAL STRAINS OF ACINETOBACTER-CALCOACETICUS [J].
JOLYGUILLO, ML ;
VALLEE, E ;
BERGOGNEBEREZIN, E ;
PHILIPPON, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (05) :597-604
[8]  
Livermore D.M., 1996, ANTIBIOTICS LAB MED, P502
[9]   BETA-LACTAMASES IN LABORATORY AND CLINICAL RESISTANCE [J].
LIVERMORE, DM .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (04) :557-&
[10]   BETA-LACTAMASE OF PSEUDOMONAS-PSEUDOMALLEI AND ITS CONTRIBUTION TO ANTIBIOTIC-RESISTANCE [J].
LIVERMORE, DM ;
CHAU, PY ;
WONG, AIW ;
LEUNG, YK .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 (03) :313-321